Skip to main content
SpringerLink
Log in

Screening for Human Parvovirus B19 Infection in Egyptian Family Replacement Blood Donors

  • Original Article
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Up till now, screening for human parvovirus B19 is not routine in national Egyptian blood bank strategy. Blood samples were collected from 500 healthy blood donors within the age range from 18 to 45 years old attending the blood bank of Suez Canal University Hospital, Ismailia, Egypt. Sera were separated and stored at − 20 °C. Serum samples were screened for anti-human parvovirus B19 IgM and IgG antibodies and B19 genome using ELISA and real-time PCR respectively. Frequency of B19 IgM and B19 IgG antibodies was 6.20%, and 80.20% respectively, and the prevalence of B19 genome was 3.00%. There is a high frequency of human parvovirus B19 among Egyptian blood donors; therefore, serological screening for B19 is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kaufman B, Simpson A, Rossmann M (2004) The structure of human parvovirus B19. P Natl Acad Sci USA 101:11628–11633

    Article  Google Scholar 

  2. Cotmore SF, Agbandje-McKenna M, Chiorini JA et al (2014) The family parvoviridae. Arch Virol 2014(159):1239–1247

    Article  Google Scholar 

  3. Bönsch C, Kempf C, Ros C (2008) Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity. J Virol 82:11784–11791

    Article  Google Scholar 

  4. Sol N, Junter J, Vassias I, Freyssiner J, Thomas A, Prigent A et al (1999) Possible interactions between the NS-1 protein and tumor necrosis factor-alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 73:8762–8770

    Article  CAS  Google Scholar 

  5. Zhi N, Mills I, Lu J, Wong S, Filippone C, Brown K (2006) Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J Virol 80:5941–5950

    Article  CAS  Google Scholar 

  6. Morita E, Tada K, Chisaka H, Asao H, Sato H, Yaegashi N, Sugamura K (2001) Human parvovirus B19 induces cell cycle arrest at G2 phase with accumulation of mitotic cyclins. J Virol 75:7555–7563

    Article  CAS  Google Scholar 

  7. Mortimer PP, Humphries RK, Moore JG, Purcell RH, Young NS (1983) A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 302:426–429

    Article  CAS  Google Scholar 

  8. Weigel-Kelley KA, Yoder MC, Chen L, Srivastava A (2006) Role of integrin cross-regulation in parvovirus B19 targeting. Hum Gene Ther 17:909–920

    Article  CAS  Google Scholar 

  9. Weigel-Kelley K, Yoder M, Srivastava A (2003) Alpha-5 beta-1 integrin as a cellular co-receptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 102:3927–3933

    Article  CAS  Google Scholar 

  10. Heegaard E, Brown K (2002) Human parvovirus B19. Clin Microbiol Rev 15:485–505

    Article  Google Scholar 

  11. Erdman DD, Anderson BC, Torok TJ, Finkel TH, Anderson LJ (1997) Possible transmission of parvovirus B19 from intravenous immune globulin. J Med Virol 53:233–236

    Article  CAS  Google Scholar 

  12. Miller E, Fairley CK, Cohen BJ, Seng C (1998) Immediate and long-term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 105:174–178

    Article  CAS  Google Scholar 

  13. Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M, Musso R et al (1997) Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization. Transfusion 37:517–522

    Article  CAS  Google Scholar 

  14. Kerr S, O’Keeffe G, Kilty C, Doyle S (1999) Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J Med Virol 57:179–185

    Article  CAS  Google Scholar 

  15. Kudesia G, Wreighitt T (2005) Parvovirus B19. In: Kudesia G, Wreighitt T (eds) Clinical and diagnostic virology. Cambridge University Press, Cambridge, pp 90–93

    Google Scholar 

  16. Corcoran A, Mahon BP, Doyle S (2004) B cell memory is directed towards conformational epitopes of parvovirus B19 capsid proteins and the VP1-unique region. J Infect Dis 189:1873–1880

    Article  CAS  Google Scholar 

  17. Michel P, Makela A, Korhonen E, Toivola J, Hedman L, Söderlund-Venermo M et al (2008) Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells. J Virol Methods 152:1–5

    Article  CAS  Google Scholar 

  18. Modrow S, Wenzel J, Schimanski S, Schwarzbeck J, Rothe U, Oldenburg J, Jilg W et al (2010) Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates. Vox Sang 100:351–358

    Article  Google Scholar 

  19. Brown KE, Young NS (1997) Human parvovirus B19: pathogenesis of disease. In: Anderson LJ, Young NS (eds) Monographs in virology, vol 20. Karger, Basel, pp 105–119

    Google Scholar 

  20. Blümel J, Schmidt I, Effenberger W, Seiz H, Willkomnen H, Brackmann HH et al (2002) Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 42:1473–1481

    Article  Google Scholar 

  21. Wu CG, Mason B, Jong J, Erdman D, McKernan L, Oakley M et al (2005) Parvovirus B19 transmission by a high-purity factor VIII concentrate. Transfusion 45:1003–1010

    Article  CAS  Google Scholar 

  22. Plentz A, Hahn J, Knoll A, Holler E, Jilg W, Modrow S (2005) Exposure of hematologic patients to Parvovirus B19 as a contaminant of blood cell preparations and blood products. Transfusion 45:1811–1815

    Article  Google Scholar 

  23. Kumar S, Gupta RM, Sen S, Sarkar RS, Philip J, Kotwal A et al (2013) Seroprevalence of human parvovirus B19 in healthy blood donors. Med J 69(2013):268–272

    Google Scholar 

  24. Al-Danani D, Abou-Donia H, Saudi M, Al-Shamahy H (2008) Seroprevalence of parvovirus B19 IgG among blood donors in Aden, Yemen and Alexandria, Egypt. J Chin Clin Med 3:173–176

    Google Scholar 

  25. Tsujimura M, Matsushita K, Shiraki H, Sato H, Okochi K, Maeda Y (1995) Human parvovirus B19 infection in blood donors. Vox Sang 69:206–212

    Article  CAS  Google Scholar 

  26. Wakamatsu C, Takakura F, Kojima E, Kiriyama Y, Goto N, Matsumoto K et al (1999) Screening of blood donors for human parvovirus B19 and characterization of the results. Vox Sang 76:14–21

    Article  CAS  Google Scholar 

  27. Hsu TC, Chen TY, Lin MC, Tzang BS, Tsay GJ (2005) Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection. J Gastroenterol Hepatol 20:733–738

    Article  CAS  Google Scholar 

  28. Khameneh ZR, Sepehrvand N, Sohrabi V, Ghasemzadeh N (2014) The seroprevalence of parvovirus B19 among kidney transplant recipients: a single-center study. Saudi J Kidney Dis Transpl 25(1):16–21

    Article  Google Scholar 

  29. Azadmanesh K, Mohraz M, Monireh Kazemimanesh M, Aghakhani A, Foroughi M, Banifazl M et al (2015) Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV. J Med Virol 87:1124–1129

    Article  CAS  Google Scholar 

  30. Sharif A, Aghakhani A, Velayati AA, Banifazl M, Sharif MR, Razeghi E et al (2016) Frequency and genotype of human parvovirus B19 among Iranian hemodialysis and peritoneal dialysis patients. Intervirology 59:179–185

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Botany, Faculty of Science, Suez Canal University, Ismailia, Egypt

    Rabab Hasanain Ahmed Hasanain & Hanaa H. Gomaa

  2. Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt

    Rania M. Saleh & Fadia M. Attia

Authors
  1. Rabab Hasanain Ahmed Hasanain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rania M. Saleh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fadia M. Attia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hanaa H. Gomaa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rania M. Saleh.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hasanain, R.H.A., Saleh, R.M., Attia, F.M. et al. Screening for Human Parvovirus B19 Infection in Egyptian Family Replacement Blood Donors. Indian J Hematol Blood Transfus 37, 309–312 (2021). https://doi.org/10.1007/s12288-020-01356-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-020-01356-y

Keywords

Search

Navigation